Therapeutic Asset Ratings
9,928 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Cabozantinib
Fallopian Tube Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Cabozantinib
Ovarian Cancer
M.D. Anderson Cancer Center
P1
CC
(43)
Cabozantinib
Renal Pelvis/Ureter Urothelial Carcinoma
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Ureter Cancer
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Systemic Lupus Erythematosus
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Systemic Sclerosis
National Cancer Institute (NCI)
P1
CC
(43)
Cabozantinib
Ulcerative Colitis
National Cancer Institute (NCI)
P1
CC
(43)
Cadvec
Salivary Gland Cancer
Baylor College of Medicine
P1
CC
(43)
Calaspargase Pegol
Myelodysplastic Syndrome
Andrew E. Place, MD
P1
CC
(43)
Calaspargase Pegol
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
Andrew E. Place, MD
P1
CC
(43)
Camibirstat
Hematopoietic And Lymphoid System Neoplasm
Foghorn Therapeutics Inc.
P1
CC
(43)
Camibirstat
Chronic Myelomonocytic Leukemia
Foghorn Therapeutics Inc.
P1
CC
(43)
Camustine
Breast Adenocarcinoma
General Oncology, Inc.
P1
CC
(43)
Camustine
PALB2-Related Cancer Predisposition
General Oncology, Inc.
P1
CC
(43)
Camustine
Pancreatic Acinar Cell Carcinoma
General Oncology, Inc.
P1
CC
(43)
can1012
Metastatic Malignant Neoplasm
CanWell Pharma Inc.
P1
CC
(43)
can1012
Ductal Breast Carcinoma In Situ
Providence Health & Services
P1
CC
(43)
can1012
Lobular Breast Carcinoma In Situ
Providence Health & Services
P1
CC
(43)
CANERPATUREV
Malignant Pancreatic Neoplasm
Takara Bio Inc.
P1
CC
(43)
Cannabis Capsules
Lip And Oral Cavity Carcinoma
Tata Memorial Hospital
P1
CC
(43)
Cap-100
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Catapult Therapeutics
P1
CC
(43)
Capivasertib
Head And Neck Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
Ovarian Clear Cell Adenocarcinoma
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
Hereditary Breast Ovarian Cancer Syndrome
M.D. Anderson Cancer Center
P1
CC
(43)
Capivasertib
BRCA2-Related Cancer Predisposition
M.D. Anderson Cancer Center
P1
CC
(43)
Showing 1426 to 1450 of 9,928 assets
Previous
Page 58 of 398
Next